Absolute and relative effects of allocation to empagliflozin on ‘total
slopes’ and ‘chronic slopes’, by pre-specified diabetes
subgroup, and post-hoc expanded eGFR and uACR subgroups
diabetes
DIABETES
P values for test of heterogeneity between absolute differences in chronic slopes
for patients with and without diabetes and tests for trend in absolute
differences in chronic slope across eGFR and UACR categories are 0.0085, 0.0013
and <0.0001 respectively. P values for test of heterogeneity between
absolute differences in total slopes for patients with and without diabetes and
tests for trend in absolute differences in total slope across eGFR and UACR
categories are 0.19, 0.023 and <0.0001 respectively.